glp-1 obesity drug news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Study finds GLP-1 receptor agonists
Description
de Oliveira Almeida G, Nienktter TF, Balieiro CCA, Pasqualotto E, Cintra JB, Carvalho HCP et al
Beyond its primary GLP-1 metabolic platform, SureNano Science is also evaluating early-stage opportunities that could expand the long-term scope of its therapeutic and delivery technology portfolio
As the disease progresses, scar tissue builds in the liver, eventually impairing its ability to function
Chris Serres: What the medications do is they produce this natural hormone, in the gut
Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, et al
